{
    "eid": "2-s2.0-85065545013",
    "title": "Cytoprotective agent for peptic ulcer prevention in patients taking dual antiplatelet agents: A randomized, double-blind placebo-controlled trial",
    "cover-date": "2019-09-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Hepatology",
            "@code": "2721",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Gastroenterology",
            "@code": "2715",
            "@abbrev": "MEDI"
        }
    ],
    "keywords": [
        "dual antiplatelet",
        "peptic ulcer",
        "prevention"
    ],
    "authors": [
        "Rapat Pittayanon",
        "Panida Piyachaturawat",
        "Rungsun Rerknimitr",
        "Piyapan Prueksapanich",
        "Supakarn Chaitongrat",
        "Vorarit Lertsuwunseri",
        "Suphot Srimahachota",
        "Varocha Mahachai"
    ],
    "citedby-count": 4,
    "ref-count": 24,
    "ref-list": [
        "Effect of clopidogrel added to aspirin in patients with atrial fibrillation",
        "Guidelines for prevention of NSAID-related ulcer complications",
        "ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents",
        "Influence of omeprazol on the antiplatelet action of clopidogrelaspirin",
        "A population-based study of the drug interaction between proton pump inhibitors and clopidogrel",
        "Ulcer prevention in long-term users of nonsteroidal anti-inflammatory drugs: results of a double-blind, randomized, multicenter, active- and placebo-controlled study of misoprostol vs lansoprazole",
        "Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: a randomized, multicenter, controlled trial-STORM STUDY",
        "Comparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantation",
        "The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group",
        "Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding",
        "Randomized clinical trial: the impact of gastrointestinal risk factor screening and prophylactic proton pump inhibitor therapy in patients receiving dual antiplatelet therapy",
        "Systematic review with meta-analysis: risk of adverse cardiovascular events with proton pump inhibitors independent of clopidogrel",
        "Impact of proton pump inhibitors and dual antiplatelet therapy cessation on outcomes following percutaneous coronary intervention: results from the PARIS registry",
        "Proton pump inhibitors and hypomagnesemia in the general population: a population-based cohort study",
        "Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients",
        "Use of proton pump inhibitors is associated with fractures in young adults: a population-based study",
        "Association of proton pump inhibitors usage with risk of pneumonia in dementia patients",
        "Proton pump inhibitor use and the risk of chronic kidney disease",
        "Risk of death among users of proton pump inhibitors: a longitudinal observational cohort study of United States veterans",
        "Rebamipide: a gastrointestinal protective drug with pleiotropic activities",
        "Stimulation of prostaglandin biosynthesis mediates gastroprotective effect of rebamipide in rats",
        "Efficacy of rebamipide for diclofenac-induced small-intestinal mucosal injuries in healthy subjects: a prospective, randomized, double-blinded, placebo-controlled, cross-over study",
        "Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury",
        "GRADE: an emerging consensus on rating quality of evidence and strength of recommendations"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60022183",
        "affilname": "King Chulalongkorn Memorial Hospital",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60022183",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Department of Medicine",
        "King Chulalongkorn Memorial Hospital",
        "Chulalongkorn University"
    ]
}